Production of glycosylated physiologically 'normal' human α1-antitrypsin by mouse fibroblasts modified by insertion of a human α1-antitrypsin cDNA using a retroviral vector

R. I. Garver, A. Chytil, S. Karlsson, G. A. Fells, M. L. Brantly, M. Courtney, P. W. Kantoff, A. W. Nienhuis, W. F. Anderson, Ronald Crystal

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

α1-Antitrypsin (α1AT) deficiency is a hereditary disorder characterized by reduced serum levels of α1AT, resulting in destruction of the lower respiratory tract by neutrophil elastase. As an approach to augment α1AT levels in this disorder with physiologically normal human α1AT, we have integrated a full-length normal human α1AT cDNA into the genome of mouse fibroblasts. To accomplish this, the retroviral vector N2 was modified by inserting the simian virus 40 early promoter followed by the α1AT cDNA. Southern analysis demonstrated that the intact cDNA was present in the genome of selected clones of the transfected murine fibroblasts ψ2 and infected NIH 3T3. The clones produced three mRNA transcripts (5.8, 4.8, and 2.4 kilobases) containing human α1AT sequences, secreted an α1AT molecule recognized by an anti-human α1AT antibody, with the same molecular mass (52 kDa) as normal human α1AT and that complexed with and inhibited human neutrophil elastase. The ψ2 produced α1AT was glycosylated, and when infused intravenously into mice, it had a serum half-life similar to normal α1AT purified from human plasma and markedly longer than that of nonglycosylated human α1AT cDNA-directed yeast-produced α1AT. These studies demonstrate the feasibility of using a retroviral vector to insert the normal human α1AT cDNA into non-α1AT-producing cells, resulting in the synthesis and secretion of physiologically 'normal' human α1AT.

Original languageEnglish
Pages (from-to)1050-1054
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume84
Issue number4
DOIs
Publication statusPublished - 8 May 1987
Externally publishedYes

Fingerprint

Complementary DNA
Fibroblasts
Leukocyte Elastase
Clone Cells
Genome
Simian virus 40
Feasibility Studies
Serum
Respiratory System
Half-Life
Yeasts
Messenger RNA
Antibodies

ASJC Scopus subject areas

  • General

Cite this

Production of glycosylated physiologically 'normal' human α1-antitrypsin by mouse fibroblasts modified by insertion of a human α1-antitrypsin cDNA using a retroviral vector. / Garver, R. I.; Chytil, A.; Karlsson, S.; Fells, G. A.; Brantly, M. L.; Courtney, M.; Kantoff, P. W.; Nienhuis, A. W.; Anderson, W. F.; Crystal, Ronald.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 84, No. 4, 08.05.1987, p. 1050-1054.

Research output: Contribution to journalArticle

Garver, R. I. ; Chytil, A. ; Karlsson, S. ; Fells, G. A. ; Brantly, M. L. ; Courtney, M. ; Kantoff, P. W. ; Nienhuis, A. W. ; Anderson, W. F. ; Crystal, Ronald. / Production of glycosylated physiologically 'normal' human α1-antitrypsin by mouse fibroblasts modified by insertion of a human α1-antitrypsin cDNA using a retroviral vector. In: Proceedings of the National Academy of Sciences of the United States of America. 1987 ; Vol. 84, No. 4. pp. 1050-1054.
@article{029791aa6d39463cb0e5f5865b078021,
title = "Production of glycosylated physiologically 'normal' human α1-antitrypsin by mouse fibroblasts modified by insertion of a human α1-antitrypsin cDNA using a retroviral vector",
abstract = "α1-Antitrypsin (α1AT) deficiency is a hereditary disorder characterized by reduced serum levels of α1AT, resulting in destruction of the lower respiratory tract by neutrophil elastase. As an approach to augment α1AT levels in this disorder with physiologically normal human α1AT, we have integrated a full-length normal human α1AT cDNA into the genome of mouse fibroblasts. To accomplish this, the retroviral vector N2 was modified by inserting the simian virus 40 early promoter followed by the α1AT cDNA. Southern analysis demonstrated that the intact cDNA was present in the genome of selected clones of the transfected murine fibroblasts ψ2 and infected NIH 3T3. The clones produced three mRNA transcripts (5.8, 4.8, and 2.4 kilobases) containing human α1AT sequences, secreted an α1AT molecule recognized by an anti-human α1AT antibody, with the same molecular mass (52 kDa) as normal human α1AT and that complexed with and inhibited human neutrophil elastase. The ψ2 produced α1AT was glycosylated, and when infused intravenously into mice, it had a serum half-life similar to normal α1AT purified from human plasma and markedly longer than that of nonglycosylated human α1AT cDNA-directed yeast-produced α1AT. These studies demonstrate the feasibility of using a retroviral vector to insert the normal human α1AT cDNA into non-α1AT-producing cells, resulting in the synthesis and secretion of physiologically 'normal' human α1AT.",
author = "Garver, {R. I.} and A. Chytil and S. Karlsson and Fells, {G. A.} and Brantly, {M. L.} and M. Courtney and Kantoff, {P. W.} and Nienhuis, {A. W.} and Anderson, {W. F.} and Ronald Crystal",
year = "1987",
month = "5",
day = "8",
doi = "10.1073/pnas.84.4.1050",
language = "English",
volume = "84",
pages = "1050--1054",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - Production of glycosylated physiologically 'normal' human α1-antitrypsin by mouse fibroblasts modified by insertion of a human α1-antitrypsin cDNA using a retroviral vector

AU - Garver, R. I.

AU - Chytil, A.

AU - Karlsson, S.

AU - Fells, G. A.

AU - Brantly, M. L.

AU - Courtney, M.

AU - Kantoff, P. W.

AU - Nienhuis, A. W.

AU - Anderson, W. F.

AU - Crystal, Ronald

PY - 1987/5/8

Y1 - 1987/5/8

N2 - α1-Antitrypsin (α1AT) deficiency is a hereditary disorder characterized by reduced serum levels of α1AT, resulting in destruction of the lower respiratory tract by neutrophil elastase. As an approach to augment α1AT levels in this disorder with physiologically normal human α1AT, we have integrated a full-length normal human α1AT cDNA into the genome of mouse fibroblasts. To accomplish this, the retroviral vector N2 was modified by inserting the simian virus 40 early promoter followed by the α1AT cDNA. Southern analysis demonstrated that the intact cDNA was present in the genome of selected clones of the transfected murine fibroblasts ψ2 and infected NIH 3T3. The clones produced three mRNA transcripts (5.8, 4.8, and 2.4 kilobases) containing human α1AT sequences, secreted an α1AT molecule recognized by an anti-human α1AT antibody, with the same molecular mass (52 kDa) as normal human α1AT and that complexed with and inhibited human neutrophil elastase. The ψ2 produced α1AT was glycosylated, and when infused intravenously into mice, it had a serum half-life similar to normal α1AT purified from human plasma and markedly longer than that of nonglycosylated human α1AT cDNA-directed yeast-produced α1AT. These studies demonstrate the feasibility of using a retroviral vector to insert the normal human α1AT cDNA into non-α1AT-producing cells, resulting in the synthesis and secretion of physiologically 'normal' human α1AT.

AB - α1-Antitrypsin (α1AT) deficiency is a hereditary disorder characterized by reduced serum levels of α1AT, resulting in destruction of the lower respiratory tract by neutrophil elastase. As an approach to augment α1AT levels in this disorder with physiologically normal human α1AT, we have integrated a full-length normal human α1AT cDNA into the genome of mouse fibroblasts. To accomplish this, the retroviral vector N2 was modified by inserting the simian virus 40 early promoter followed by the α1AT cDNA. Southern analysis demonstrated that the intact cDNA was present in the genome of selected clones of the transfected murine fibroblasts ψ2 and infected NIH 3T3. The clones produced three mRNA transcripts (5.8, 4.8, and 2.4 kilobases) containing human α1AT sequences, secreted an α1AT molecule recognized by an anti-human α1AT antibody, with the same molecular mass (52 kDa) as normal human α1AT and that complexed with and inhibited human neutrophil elastase. The ψ2 produced α1AT was glycosylated, and when infused intravenously into mice, it had a serum half-life similar to normal α1AT purified from human plasma and markedly longer than that of nonglycosylated human α1AT cDNA-directed yeast-produced α1AT. These studies demonstrate the feasibility of using a retroviral vector to insert the normal human α1AT cDNA into non-α1AT-producing cells, resulting in the synthesis and secretion of physiologically 'normal' human α1AT.

UR - http://www.scopus.com/inward/record.url?scp=0023134085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023134085&partnerID=8YFLogxK

U2 - 10.1073/pnas.84.4.1050

DO - 10.1073/pnas.84.4.1050

M3 - Article

C2 - 3029759

AN - SCOPUS:0023134085

VL - 84

SP - 1050

EP - 1054

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -